Comparision of the Use in Marcaine and Chloroprocaine in Rachianesthesia for the Surgical Correction of Inguinal Hernia.

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02049255

Enrollment

Registered

2014-01-30

Start date

2013-11-30

Completion date

2014-10-31

Last updated

2014-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

All

Brief summary

Comparison the use of marcaine and chloroprocaine in rachianesthesia for a surgical correction of inguinal hernia. Comparision between acute and chronic (3 months and 6 months) pain.

Interventions

DRUGChloroprocaine

The Group Chloroprocaine will receive: Chloroprocaine: 50 mg in rachianesthesia

DRUGMarcaine

The Group Marcaine will receive: Marcaine: 12,5 mg in rachianesthesia

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Adults under rachianesthesia

Exclusion criteria

* Personal history of gastric ulcus * ASA 4 * Emergency * Combined surgery

Design outcomes

Primary

Measure	Time frame
Acute pain	1 day of the surgery when patient leave the recovery room

Secondary

Measure	Time frame
Chronic pain	at 3 and 6 months

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026